North America

UK cybersecurity company Darktrace valued at $1.65 bln after latest funding

Cambridge, U.K.-based Darktrace, which uses machine learning and AI algorithms to provide cyber defense services, announced that it has raised $50 million in Series E funding led by Vitruvian Partners. Existing investors KKR and 1011 Ventures also participated. The latest funding now values the company at $1.65 billion. Darktrace, founded in 2013, has now raised $229 million in funding.

SenseHawk procures $2 mln

San Francisco, Mumbai and Bengaluru-based SenseHawk, a intelligent cloud-based platform focused on the energy and infrastructure sector, has raised $2 million in funding. The investor was SAIF Partners.

Morningside raises $593 mln for venture-capital, opportunity funds

Morningside Venture Capital has raised $395.5 million toward a $600 million venture-capital fund, according to a filing with the SEC. The Hong Kong firm also raised $197.8 million toward a $300 million opportunity fund, a separate filling shows.

Breakthrough leads latest round of CO2 tech platform CarbonCure

CarbonCure Technologies Inc, a Halifax-based carbon dioxide (CO2) utilization platform, has secured undisclosed financing. The round was led by Breakthrough Energy Ventures, a U.S.-based clean energy fund. It was joined by GreenSoil Building Innovation Fund as well as existing investors, including BDC Capital's ICE Venture Fund, Pangaea Ventures, 350 Capital, Innovacorp, Brightpath Capital Partners, Neo Ventures, Shaw Group, Power Generations and Carmanah Management. Founded in 2007 by CEO Rob Niven, CarbonCure develops CO2 utilization technologies for the concrete sector, helping to reduce concrete’s carbon footprint and create efficiencies. It will use the funds raised to grow its solutions portfolio and enter new markets.

Data.world reels in $12 mln

Austin, Texas-based Data.world, a platform for modern data teamwork, has secured $12 million in funding. The investors were Workday Ventures, The Associated Press and OurCrowd.

VC-backed Entasis Therapeutics debuts IPO

Waltham, Massachusetts-based Entasis Therapeutics, a biopharmaceutical company focused on developing new antibacterial products, has raised about $75 million for its IPO after pricing its 5 million shares at $15 per share. The stock began trading September 26, 2018 on the NASDAQ under the ticker symbol "ETTX." Credit Suisse and BMO Capital Markets are the lead underwriters. Entasis' pre-IPO backers include Pivotal bioVenture Partners, Sofinnova Ventures and TPG Biotech.

Ceribell fetches $35 mln Series B

Mountain View, California-based Ceribell Inc, a provider of a system that diagnoses and treats patients at risk for seizures, has secured $35 million in Series B financing. Optimas Capital Partners Fund and The Rise Fund led the round with participation from UCB and LivaNova.

Morphic Therapeutic nets $80 mln Series B

Morphic Therapeutic, a developer of oral integrin therapies, has raised $80 million in Series B financing. Omega Funds and Novo Holdings led the round with participation from other investors that included Invus and EcoR1 Capital.

TapClicks scores $10 mln from Boathouse Capital

San Jose, California-based TapClicks, a provider of marketing analytics, reporting and workflow, has raised $10 million in funding. The investor was Boathouse Capital.

Nautilus Venture Partners targets $150 mln for sophomore fund

Nautilus Venture Partners is seeking to raise $150 million for its second fund, according to an SEC filing. The Cupertino, California-based early-stage venture firm focused on helping startups partner with large tech companies.